Acyclovir (Compound)

Synonyms:acyclovir, Aciclovir, Acycloguanosine, 59277-89-3, Zovirax, Vipral, Virorax, Wellcome-248U, 9-[(2-Hydroxyethoxy)methyl]guanine, Aciclovirum, 2-Amino-9-((2-hydroxyethoxy)methyl)-1H-purin-6(9H)-one, Sitavig, Zovir, Acyclovir-side chain-2-3H, Gerpevir, 9-(2-Hydroxyethoxy)methylguanine, 9-HYROXYETHOXYMETHYLGUANINE, W-248-U, 9-((2-Hydroxyethoxy)methyl)guanine, Novirus, 141294-79-3, 2-Amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-6H-purin-6-one, Aciclovir [INN], MFCD00057880, NSC 645011, CHEBI:2453, 2-amino-9-(2-hydroxyethoxymethyl)-1H-purin-6-one, 2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one, Acyclovir (Aciclovir), 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one, 6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-, ACYCLOVIR-SIDECHAIN-2-3H, Zovirax (TN), 9-[(2-Hydroxyethoxy)-methyl]guanine, NSC-645011, NSC-758477, 2-Amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin-6-one, X4HES1O11F, MLS000069633, Activir, DTXSID1022556, 9-(2-Hydroxyethoxymethyl)guanine, 6H-Purin-6-one, 2-amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-, NSC645011, AC2, Acyclovir [USAN], 2-amino-9-((2-hydroxyethoxy)methyl)-3H-purin-6(9H)-one, NCGC00015061-02, Aciclovirum [Latin], Aciclovier, Hascovir, SMR000058225, Genvir, Maynar, Zyclir, 2-amino-9-[(2-hydroxyethoxy)methyl]-6,9-dihydro-3H-purin-6-one, CAS-59277-89-3, 6H-Purin-6-one, 1,9-dihydro-2-amino-9-((2-hydroxyethoxy)methyl)-, 2-amino-9-(2-hydroxyethoxymethyl)purin-6-ol, Aciclovirum [INN-Latin], DTXCID102556, Acicloftal, Cargosil, Viropump, AcycloFoam, 2-amino-9-[(2-hydroxyethoxy)methyl]-3,9-dihydro-6H-purin-6-one, Acic, BW-248U, 2-amino-9-{[(2-hydroxyethyl)oxy]methyl}-1,9-dihydro-6H-purin-6-one, Acyclo-V, Acyclovir Lauriad, DRG-0008, Acyclovir (USP), BW 248U, CCRIS 1953, HSDB 6511, SR-01000075540, Acyclovir [USAN:USP], EINECS 261-685-1, ACV & Pluronic F-68, UNII-X4HES1O11F, Acyclovir & Pluronic F-68, Cyclovir, Poviral, Sitavir, 2-amino-9-((2-hydroxyethoxy)methyl)-3,9-dihydro-6H-purin-6-one, Prestwick_6, 1pwy, BW-248-U, Sitavig (TN), AVACLYR, Spectrum_001739, ACICLOVIR [JAN], ACYCLOVIR [MI], ACICLOVIR [IARC], ACYCLOVIR [HSDB], Opera_ID_1674, Prestwick0_000086, Prestwick1_000086, Prestwick2_000086, Prestwick3_000086, Spectrum2_001563, Spectrum3_001874, Spectrum4_000225, Spectrum5_001093, ACYCLOVIR [VANDF], Lopac-A-4669, Aciclovir (JP17/INN), ACICLOVIR [MART.], CHEMBL184, A 4669, ACICLOVIR [WHO-DD], ACICLOVIR [WHO-IP], ACYCLOVIR [USP-RS], SCHEMBL3175, Lopac0_000037, ACICLOVIRUM [WHO-IP], BSPBio_000012, BSPBio_003348, KBioGR_000889, KBioSS_002219, BIDD:GT0646, DivK1c_000185, SPECTRUM1503603, SPBio_001466, SPBio_001951, 2-amino-9-[(2-hydroxyethoxy)methyl]hydropurin-6-one, BPBio1_000014, GTPL4829, SCHEMBL9828560, 9(2-hydroxyethoxymethyl)guanine, ACYCLOVIR [ORANGE BOOK], ACICLOVIR [EP MONOGRAPH], HMS500J07, KBio1_000185, KBio2_002219, KBio2_004787, KBio2_007355, KBio3_002850, ACYCLOVIR [USP MONOGRAPH], NINDS_000185, HMS1568A14, HMS1922E08, HMS2090G09, HMS2095A14, HMS2234K21, HMS3259N10, HMS3260G15, HMS3269M15, HMS3372K02, HMS3413D21, HMS3655C14, HMS3677D21, HMS3712A14, Pharmakon1600-01503603, BCP11036, 9-(2-hydroxyethoxy methyl) guanine, Tox21_110075, Tox21_500037, BBL009642, BDBM50021776, BDBM50103518, CCG-39909, NSC758477, NSC780378, s1807, STK796771, STL257059, STL301862, AKOS000656213, AKOS015995680, AKOS022135433, Tox21_110075_1, AC-8068, CS-1353, DB00787, KS-1027, LP00037, NC00717, NSC-780378, SDCCGSBI-0050026.P003, IDI1_000185, SMP1_000007, NCGC00015061-01, NCGC00015061-03, NCGC00015061-04, NCGC00015061-05, NCGC00015061-06, NCGC00015061-07, NCGC00015061-08, NCGC00015061-09, NCGC00015061-10, NCGC00015061-12, NCGC00015061-13, NCGC00015061-28, NCGC00015061-29, NCGC00022426-03, NCGC00093555-01, NCGC00093555-02, NCGC00093555-03, NCGC00093555-04, NCGC00167756-01, NCGC00167756-02, NCGC00260722-01, NCGC00381719-03, HY-17422, SY051130, Acycloguanosine, >=99% (HPLC), powder, Aciclovir 1.0 mg/ml in Dimethyl Sulfoxide, AM20100442, EU-0100037, FT-0621607, FT-0657847, SW196324-3, C06810, D00222, EN300-123010, A832236, A935190, Q147101, Q-200591, SR-01000075540-1, SR-01000075540-3, SR-01000075540-5, 2-amino-9-[(2-hydroxyethoxy)methyl]-9H-purin-6-ol, 2-azanyl-9-(2-hydroxyethyloxymethyl)-3H-purin-6-one, BRD-K32318651-001-17-9, Aciclovir, British Pharmacopoeia (BP) Reference Standard, F2173-0946, Z1546610471, Aciclovir, European Pharmacopoeia (EP) Reference Standard, VALACICLOVIR HYDROCHLORIDE IMPURITY B [EP IMPURITY], 2-Amino-9-(2-hydroxy-ethoxymethyl)-5,9-dihydro-purin-6-one, Acyclovir, United States Pharmacopeia (USP) Reference Standard, 2-Amino-9-(2-hydroxy-ethoxymethyl)-5,9-dihydro-purin-6-one (ACV), 2-Amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin-6-one #, VALACICLOVIR HYDROCHLORIDE HYDRATE IMPURITY B [EP IMPURITY], ACV; Acycloguanosine; Acyclovir; NSC 645011; NSC-645011; NSC645011, Acyclovir, Pharmaceutical Secondary Standard; Certified Reference Material, Aciclovir for peak identification 1, European Pharmacopoeia (EP) Reference Standard, Aciclovir for peak identification 2, European Pharmacopoeia (EP) Reference Standard, Aciclovir for system suitability, European Pharmacopoeia (EP) Reference Standard

Pubchem:PUBCHEM:2022

Id:75721ac6-cf5c-5a57-b9e5-0a428d54212c

Description:nan